Literature DB >> 11786899

Tumor-specific mutations in p53: the acid test.

Pierre Hainaut.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11786899     DOI： 10.1038/nm0102-21

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  8 in total

1.  CRINEPT-TROSY NMR reveals p53 core domain bound in an unfolded form to the chaperone Hsp90.

Authors:  Stefan Rudiger; Stefan M V Freund; Dmitry B Veprintsev; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-05       Impact factor: 11.205

2.  Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.

Authors:  Jonathan D Wasserman; Ana Novokmet; Claudia Eichler-Jonsson; Raul C Ribeiro; Carlos Rodriguez-Galindo; Gerard P Zambetti; David Malkin
Journal:  J Clin Oncol       Date:  2015-01-12       Impact factor: 44.544

3.  DNA methylation patterns of candidate genes regulated by thymine DNA glycosylase in patients with TP53 germline mutations.

Authors:  F P Fortes; H Kuasne; F A Marchi; P M Miranda; S R Rogatto; M I Achatz
Journal:  Braz J Med Biol Res       Date:  2015-04-28       Impact factor: 2.590

4.  A TP53 founder mutation, p.R337H, is associated with phyllodes breast tumors in Brazil.

Authors:  Juliana Giacomazzi; Patricia Koehler-Santos; Edenir Inez Palmero; Marcia S Graudenz; Luis Fernando Rivero; Eduardo Lima; Antonio Carlos Kruel Pütten; Pierre Hainaut; Suzi Alves Camey; Rodrigo Depieri Michelli; Cristovam Scapulatempo Neto; Mariana Fitarelli-Kiehl; Geraldo Geyer; Luise Meurer; Ana Geiger; Monica Blaya Azevedo; Vinicius Duval da Silva; Patricia Ashton-Prolla
Journal:  Virchows Arch       Date:  2013-06-21       Impact factor: 4.064

5.  Childhood adrenocortical tumours: a review.

Authors:  Rosana Marques-Pereira; Luiz Delacerda; Hadriano M Lacerda; Edson Michalkiewicz; Fabiano Sandrini; Romolo Sandrini
Journal:  Hered Cancer Clin Pract       Date:  2006-05-15       Impact factor: 2.857

6.  Increased oxidative damage in carriers of the germline TP53 p.R337H mutation.

Authors:  Gabriel S Macedo; Leonardo Lisbôa da Motta; Juliana Giacomazzi; Cristina B O Netto; Vanusa Manfredini; Camila S Vanzin; Carmen Regla Vargas; Pierre Hainaut; Fábio Klamt; Patricia Ashton-Prolla
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

7.  Transitions at CpG dinucleotides, geographic clustering of TP53 mutations and food availability patterns in colorectal cancer.

Authors:  Fabio Verginelli; Faraz Bishehsari; Francesco Napolitano; Mahboobeh Mahdavinia; Alessandro Cama; Reza Malekzadeh; Gennaro Miele; Giancarlo Raiconi; Roberto Tagliaferri; Renato Mariani-Costantini
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

8.  TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient.

Authors:  Juliana Giacomazzi; Simone Selistre; Juliana Duarte; Jorge Pinto Ribeiro; Paulo J C Vieira; Gabriel de Souza Macedo; Cristina Rossi; Mauro Czepielewski; Cristina Brinkmann Oliveira Netto; Pierre Hainaut; Patricia Ashton-Prolla
Journal:  BMC Cancer       Date:  2013-04-09       Impact factor: 4.430
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.